Johannes Leierer

Head of Laboratory

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Johannes Leierer is the Head of Laboratory at the Medical University Innsbruck, Austria. His research interests encompass diabetic kidney disease, ANCA-associated vasculitis, and chronic kidney disease, as evidenced by his recent publications on urinary biomarkers, inflammatory responses, and disease progression. Leierer has also contributed to understanding the mechanisms of autosomal dominant polycystic kidney disease and the implications of empagliflozin on inflammatory processes in kidney cells.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Mark Ibberson

SIB Swiss Institute of Bioinformatics

SWITZERLAND

View details

Markus Pirklbauer

Assistant Professor

Medical University of Innsbruck

AUSTRIA

View details

DUVURU GEETHA

ASSOCIATE PROFESSOR OF MEDICINE

Johns Hopkins University

UNITED STATES

View details

Maria Vanessa Perez-Gomez

Universidad Autónoma de Madrid

SPAIN

View details

Dita Maixnerova

Assoc. Prof

Charles University, First Faculty of Medicine

CZECH REPUBLIC

View details

Verena Vogi

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Johannes Leierer

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Association of Urinary Epidermal Growth Factor, Fatty Acid-Binding Protein 3, and Vascular Cell Adhesion Molecule 1 Levels with the Progression of Early Diabetic Kidney Disease

Risk factors for serious infections in ANCA-associated vasculitis

Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study.

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis

Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease

Urine proteomics for prediction of disease progression in patients with IgA nephropathy.

Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells.

Comorbidities in ANCA-associated vasculitis.

Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.

Collaborators (6)

Mark Ibberson

Markus Pirklbauer

DUVURU GEETHA

Maria Vanessa Perez-Gomez

Dita Maixnerova

Verena Vogi

Make your next move.